Anti-Inflammatory Activity and Mechanism of Isookanin, Isolated by Bioassay-Guided Fractionation from Bidens pilosa L.
- Authors
- Xin, Ying-Ji; Choi, Soojung; Roh, Kyung-Baeg; Cho, Eunae; Ji, Hyanggi; Weon, Jin Bae; Park, Deokhoon; Whang, Wan Kyunn; Jung, Eunsun
- Issue Date
- Jan-2021
- Publisher
- MDPI
- Keywords
- isookanin; Bidens pilosa L; bioassay-guided isolation; anti-inflammatory
- Citation
- MOLECULES, v.26, no.2
- Journal Title
- MOLECULES
- Volume
- 26
- Number
- 2
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/47608
- DOI
- 10.3390/molecules26020255
- ISSN
- 1420-3049
1420-3049
- Abstract
- Bidens pilosa L. (Asteraceae) has been used historically in traditional Asian medicine and is known to have a variety of biological effects. However, the specific active compounds responsible for the individual pharmacological effects of Bidens pilosa L. (B. pilosa) extract have not yet been made clear. This study aimed to investigate the anti-inflammatory phytochemicals obtained from B. pilosa. We isolated a flavonoids-type phytochemical, isookanin, from B. pilosa through bioassay-guided fractionation based on its capacity to inhibit inflammation. Some of isookanin's biological properties have been reported; however, the anti-inflammatory mechanism of isookanin has not yet been studied. In the present study, we evaluated the anti-inflammatory activities of isookanin using lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages. We have shown that isookanin reduces the production of proinflammatory mediators (nitric oxide, prostaglandin E-2) by inhibiting the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in LPS-stimulated macrophages. Isookanin also inhibited the expression of activator protein 1 (AP-1) and downregulated the LPS-induced phosphorylation of p38 mitogen-activated protein kinase (MAPK) and c-jun NH2-terminal kinase (JNK) in the MAPK signaling pathway. Additionally, isookanin inhibited proinflammatory cytokines (tumor necrosis factor-a (TNF-alpha), interleukin-6 (IL-6), interleukin-8 (IL-8), and interleukin-1 beta (IL-1 beta)) in LPS-induced THP-1 cells. These results demonstrate that isookanin could be a potential therapeutic candidate for inflammatory disease.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Pharmacy > School of Pharmacy > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/47608)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.